CervoMed Inc. (NASDAQ: CRVO)
$19.73
+1.7200 ( +9.55% ) 120.2K
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Market Data
Open
$19.73
Previous close
$18.01
Volume
120.2K
Market cap
$163.18M
Day range
$17.62 - $20.35
52 week range
$4.28 - $26.38
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 12, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
8-k | 8K-related | 16 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
8-k | 8K-related | 19 | May 20, 2024 |